Scientists say marijuana doesn’t ease anxiety or other mental health conditions
Recent research shows no evidence of medicinal cannabis effectiveness treating anxiety. Patients often self-medicate, but clinical trials do not support cannabis for mental health relief. Clinicians recommend evidence-based treatments over cannabis for…
Medical Cannabis Use Grows in West Virginia; Research Opportunities May Shed More Light
Medical cannabis research opportunities are expanding in West Virginia as use increases statewide. This growth highlights the need for better clinical evidence to guide safe and effective cannabinoid therapy. New policies aim to remove barriers and…
Mississippi Bill Expanding Medical Cannabis Heads to Governor – NORML
Mississippi medical cannabis research authorization is expanding under new legislation. This change could increase clinical evidence for cannabis efficacy and safety. Clinicians should monitor how this impacts patient care and research oversight.
Study Finds No Benefit of Psychedelic Therapy Over Antidepressants
The psychedelic therapy study reveals no significant benefit of psychedelic therapy compared to antidepressants. This research highlights the need for careful evaluation of treatment options for depression. Understanding these findings helps clinicians…
In the Mix: Cannabis Clinical Research and Industry Updates — March 19, 2026
This update highlights key developments in cannabis clinical research platforms advancing evidence-based therapeutics. Regulatory and labor frameworks are maturing alongside these research efforts. Market supply challenges and financial compliance issues…
The Right Schedule for Marijuana Does Not Yet Exist
2026 cannabis schedule classification challenges create significant legal barriers that limit clinical research. These challenges hinder establishing evidence-based dosing and safety profiles. Until reforms align with science, clinicians face…
Alcohol and Tobacco Are More Damaging Than Marijuana: Clinical Insights
Comparative harm alcohol tobacco cannabis research reveals alcohol and tobacco cause greater population-level damage than marijuana. This evidence supports nuanced patient counseling about relative risks. Clinicians can prioritize substance use…
High Marijuana Taxes Don’t Effectively Deter Use, Study Shows
Recent research reveals cannabis tax increases patient use may not effectively reduce consumption. Higher taxes can drive patients toward unregulated markets, limiting clinical oversight. This challenges the use of taxation as a sole policy tool to deter…
Psychedelics May Be No Better Than Antidepressants for Depression: Studies – ABC News
Recent psychedelics depression studies suggest these treatments may not outperform established antidepressants. Clinicians should counsel patients on evidence gaps regarding psychedelics for depression. This underscores the importance of evidence-based…
Virginia Moves to Launch Legal Cannabis Marketplace After Years of Delay | Government
Virginia cannabis regulatory framework is key to launching a legal marketplace after years of delay. This framework improves patient access and product safety. Clinicians benefit from clearer guidance on cannabis use and product standards.